4.7 Review

Fibrin clot properties in cardiovascular disease: from basic mechanisms to clinical practice

Related references

Note: Only part of the references are listed.
Article Cardiac & Cardiovascular Systems

Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association

Connie W. Tsao et al.

Summary: This article introduces the latest statistics on heart disease, stroke, and cardiovascular risk factors published by the American Heart Association in conjunction with the National Institutes of Health. The Statistical Update includes data on a range of clinical heart and circulatory disease conditions and their associated outcomes. It serves as a critical resource for the general public, policymakers, healthcare professionals, researchers, and others seeking the best available data.

CIRCULATION (2022)

Article Critical Care Medicine

Aberrant Fibrin Clot Structure Visualized Ex Vivo in Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection

Lisa S. Brubaker et al.

Summary: This cross-sectional observational study found aberrant fibrin clot structure and function in critically ill patients with COVID-19. These findings may be associated with the poor outcomes observed in COVID-19 patients with widespread fibrin deposition.

CRITICAL CARE MEDICINE (2022)

Review Biochemistry & Molecular Biology

Fibrinogen and Atherosclerotic Cardiovascular Diseases-Review of the Literature and Clinical Studies

Stanislaw Surma et al.

Summary: Atherosclerotic cardiovascular diseases (ASCVD) are a major cause of premature death worldwide. Biomarkers that can detect and assess the prognosis of ASCVD are highly sought after. Fibrinogen, a protein that increases in concentration in ASCVD patients, may serve as a biomarker for the disease and contribute to its development through genetic polymorphisms and post-translational modifications.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Hematology

Fibrin to von Willebrand factor ratio in arterial thrombi is associated with plasma levels of inflammatory biomarkers and local abundance of extracellular DNA

Erzsebet Toth et al.

Summary: The composition of thrombi plays a crucial role in determining their structure, stability, susceptibility to lysis, and clinical outcomes in various cardiovascular diseases. The interplay between VWF/NET/fibrin axis in arterial thrombosis highlights the complexity of thrombus constituents and their relationships with systemic inflammatory biomarkers.

THROMBOSIS RESEARCH (2022)

Article Medicine, General & Internal

8-Isoprostanes and Asymmetric Dimethylarginine as Predictors of Mortality in Patients Following Coronary Bypass Surgery: A Long-Term Follow-Up Study

Aleksandra Golab et al.

Summary: This study found that markers of oxidative stress and nitric oxide bioavailability can predict cardiovascular mortality following bypass surgery during long-term follow-up. Increased 8-iso-prostaglandin F2 alpha before surgery and enhanced asymmetric dimethylarginine accumulation after the surgery are associated with cardiovascular death in patients with advanced coronary disease.

JOURNAL OF CLINICAL MEDICINE (2022)

Article Hematology

Altered fibrin clot structure and dysregulated fibrinolysis contribute to thrombosis risk in severe COVID-19

Malgorzata Wygrecka et al.

Summary: The altered levels of factor XII (FXII) and its activation products contribute to the high incidence of thrombotic events in COVID-19 patients. COVID-19 patients exhibit rapid consumption of FXII and no prolonged lag phase in fibrin formation triggered by the FXII activator kaolin, unlike patients with ARDS-influenza. Confocal and electron microscopy analysis show that COVID-19 patients form compact clots with thin fibers and small pores, leading to impaired clot lysis. Widespread compact fibrin deposits are observed in the lung tissue of COVID-19 patients.

BLOOD ADVANCES (2022)

Article Hematology

Lifestyle Influences Changes in Fibrin Clot Properties Over a 10-Year Period on a Population Level

Albe Carina Swanepoel et al.

Summary: In this population study, factors such as female gender, obesity, poor glycemic control, increased low-density lipoprotein cholesterol, and decreased high-density lipoprotein cholesterol were associated with progression to prothrombotic clot properties with age. In contrast, alcohol consumption had a protective effect.

THROMBOSIS AND HAEMOSTASIS (2022)

Review Cardiac & Cardiovascular Systems

Beyond fibrinolysis: The confounding role of Lp(a) in thrombosis

Michael B. Boffa

Summary: Elevated Lp(a) levels are a causal risk factor for atherothrombotic disorders, but the exact pathological mechanisms are not fully understood.

ATHEROSCLEROSIS (2022)

Article Cardiac & Cardiovascular Systems

Apolipoproteins and lipoprotein(a) as factors modulating fibrin clot properties in patients with severe aortic stenosis

Jakub Siudut et al.

Summary: This study investigated the impact of apolipoproteins and oxidized low-density lipoprotein on the prothrombotic fibrin clot phenotype in patients with aortic stenosis. The results showed positive associations between apolipoproteins and oxidized low-density lipoprotein with fibrin clot properties, as well as negative associations with fibrinolytic capacity. This suggests that elevated lipoproteins may play an important role in promoting blood coagulation.

ATHEROSCLEROSIS (2022)

Article Medicine, General & Internal

Impaired fibrin clot lysis is associated with increased mortality in patients after coronary artery bypass grafting: A long-term follow-up study

Aleksandra Golab et al.

Summary: This study suggests that reduced fibrinolysis capacity is associated with long-term mortality in patients with advanced coronary artery disease (CAD).

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2022)

Review Hematology

Why fibrin biomechanical properties matter for hemostasis and thrombosis

Timea Feller et al.

Summary: Polymer fibrin plays a unique role in blood clot formation, with specific biomechanical properties that impact its function. The formation and structure of fibrin fibers, as well as the relationship between structure and biomechanical properties, are key factors in understanding its role in clot formation and thromboembolic disease. Studying fibrin biomechanics is crucial for preventing conditions such as pulmonary embolism, and additional research is needed to fully understand the molecular structure and mechanical properties of fibrin.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)

Review Cardiac & Cardiovascular Systems

Inflammation, Aging, and Cardiovascular Disease JACC Review Topic of the Week

Luca Liberale et al.

Summary: Aging and inflammation both play key roles in cardiovascular and cerebrovascular diseases, recognizing the concept of inflamm-aging can lead to new therapeutic targets and options for the growing aging population. This review discusses recent scientific advances in understanding the pathways of inflamm-aging and its potential implications in clinical practice.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2022)

Article Hematology

Markers of NET formation and stroke risk in patients with atrial fibrillation: association with a prothrombotic state

Patrycja Molek et al.

Summary: Increased levels of circulating NETs markers associated with a hypercoagulable state may predispose anticoagulated AF patients to ischemic stroke, indicating a prognostic value of NETosis in AF.

THROMBOSIS RESEARCH (2022)

Article Pharmacology & Pharmacy

Intensive low-density lipoprotein cholesterol lowering improves fibrin clot properties: Association with lipoproteins and C-reactive protein

Jakub Siudut et al.

Summary: This study investigated the effect of statins on fibrin clot phenotype in patients with coronary artery disease (CAD). The results showed that high-dose statin treatment led to a decrease in LDL-C and improved fibrin clot properties, including increased permeability and shorter clot lysis time. Patients who achieved the therapeutic LDL-C goal had more significant improvements in fibrin clot phenotype compared to those who did not achieve the goal.

VASCULAR PHARMACOLOGY (2022)

Article Hematology

Fibrin protofibril packing and clot stability are enhanced by extended knob-hole interactions and catch-slip bonds

Nathan L. Asquith et al.

Summary: This study investigated the interactions between knobs and holes during fibrin polymerization and their effects on fiber formation, clot structure, and clot mechanics.

BLOOD ADVANCES (2022)

Article Cardiac & Cardiovascular Systems

Elevated 8-isoprostane concentration is associated with thromboembolic events in patients with atrial fibrillation

Patrycja Molek et al.

Summary: This study found that increased levels of 8-isoprostane are associated with thromboembolic events in patients with atrial fibrillation despite anticoagulant therapy, providing evidence for the impact of oxidative stress on the efficacy of anticoagulation.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2022)

Article Biochemistry & Molecular Biology

Mass-spectrometric identification of oxidative modifications in plasma-purified plasminogen: Association with hypofibrinolysis in patients with acute pulmonary embolism

Agata Hanna Bryk-Wiazania et al.

Summary: This study found that impaired fibrinolysis in patients with acute pulmonary embolism (PE) may be attributed to oxidative stress-induced changes in plasminogen molecules. Various modifications in plasminogen were identified using mass spectrometry, including modifications at sites involved in important biological functions.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2022)

Article Hematology

Determinants of plasma fibrin clot lysis measured using three different assays in healthy subjects

Jakub Siudut et al.

Summary: Apart from PAI-1, TAFI, and α(2)-antiplasmin, several other factors, particularly CRP, can affect the results of global fibrinolysis tests used in research.

THROMBOSIS RESEARCH (2021)

Review Hematology

The Clotting Trigger Is an Important Determinant for the Coagulation Pathway In Vivo or In Vitro-Inference from Data Review

Shu He et al.

Summary: Blood coagulation involves enzymatic reactions leading to thrombin and fibrin formation. In vivo, the cascade is initiated through tissue factor, while in vitro a small amount of recombinant TF is used. Global hemostasis assays can evaluate coagulation disorders or therapy effects.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2021)

Review Biochemistry & Molecular Biology

Fibrinogen and Antifibrinolytic Proteins: Interactions and Future Therapeutics

Nikoletta Pechlivani et al.

Summary: Targeting proteins involved in hypofibrinolysis represents a specific approach for developing effective and safe therapeutic agents to reduce thrombosis risk and improve clot instability in bleeding disorders.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Cardiac & Cardiovascular Systems

Plasma fibrin clot properties and cardiovascular mortality in patients with type 2 diabetes: a long-term follow-up study

Agata Hanna Bryk et al.

Summary: This study found that the formation of denser fibrin clots resistant to fibrinolysis could be a risk factor for long-term cardiovascular mortality in patients with type 2 diabetes mellitus (T2DM), especially those with prior cardiovascular disease.

CARDIOVASCULAR DIABETOLOGY (2021)

Editorial Material Cardiac & Cardiovascular Systems

Biomarkers for atrial fibrillation and chronic kidney disease: what is the evidence?

Rungroj Krittayaphong et al.

KARDIOLOGIA POLSKA (2021)

Article Cardiac & Cardiovascular Systems

Thromboembolism and bleeding in patients with atrial fibrillation and stage 4 chronic kidney disease: impact of biomarkers

Pawel T. Matusik et al.

Summary: In this study, it was found that age and decreased clot permeability were associated with thromboembolic events in AF patients with CKD. Previous bleeding, growth differentiation factor-15, cystatin C, and high-sensitivity cardiac troponin T were independent predictors of major or clinically relevant non-major bleeding. After adjusting for age and comorbidities, only cystatin C was found to predict mortality risk.

KARDIOLOGIA POLSKA (2021)

Review Cardiac & Cardiovascular Systems

Diabetes mellitus as a risk factor for aortic stenosis: from new mechanisms to clinical implications

Joanna Natorska

Summary: Aortic stenosis (AS) is a progressive disease with no pharmacological treatment, and diabetes mellitus (DM) increases the risk of AS development. The influence of hyperglycemia on valvular calcification is not fully understood. Transcatheter aortic valve replacement (TAVI) is safer for AS patients with concomitant DM, and new antidiabetic drugs may reduce the risk of AS development in DM patients by targeting inhibition of AGEs-mediated oxidative stress.

KARDIOLOGIA POLSKA (2021)

Review Clinical Neurology

Thrombus Composition and Efficacy of Thrombolysis and Thrombectomy in Acute Ischemic Stroke

Precious Jolugbo et al.

Summary: Thrombi in stroke are highly heterogeneous, consisting of fibrin, platelets, red blood cells, VWF, and neutrophil extracellular traps. These thrombi can be roughly divided into fibrin-rich and red blood cell-rich clots. Fibrin-rich clots are associated with increased recanalization maneuvers, longer procedure times, and less favorable clinical outcomes compared with red blood cell-rich clots.

STROKE (2021)

Article Cardiac & Cardiovascular Systems

Patients scheduled for TAVI tend to form abnormal fibrin clots more resistant to lysis: the impact of age

Maria Jaworska-Wilczynska et al.

Summary: This study found that patients scheduled for TAVI exhibit prothrombotic fibrin clot properties, including denser fibrin meshwork and higher resistance to lysis compared to those undergoing SAVR, potentially contributing to an increased risk of thromboembolism following TAVI.

KARDIOLOGIA POLSKA (2021)

Editorial Material Cardiac & Cardiovascular Systems

Biomarkers in atrial fibrillation: a constant search for simplicity, practicality, and cost-effectiveness

Giuseppe Boriani et al.

KARDIOLOGIA POLSKA (2021)

Article Hematology

Fibrinolysis in Acute and Chronic Cardiovascular Disease

Noppadol Kietsiriroje et al.

Summary: The formation of an obstructive thrombus within an artery is a major cause of mortality and morbidity worldwide. Despite effective inhibition of platelet function by modern antiplatelet therapies, these agents fail to fully eliminate atherothrombotic risk. Recent evidence suggests that residual vascular risk in those treated with modern antiplatelet therapies is related, at least in part, to impaired fibrin clot lysis.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2021)

Review Cardiac & Cardiovascular Systems

Hypofibrinolysis in type 2 diabetes and its clinical implications: from mechanisms to pharmacological modulation

Agata Hanna Bryk-Wiazania et al.

Summary: A prothrombotic state is a common feature of type 2 diabetes mellitus, characterized by increased platelet reactivity, endothelial dysfunction, hyperfibrinogenemia, and hypofibrinolysis. Various complex mechanisms contribute to impaired fibrinolysis in T2DM, with abnormal fibrin clot structure playing a pivotal role. Enhanced thrombin generation, proinflammation, neutrophil extracellular trap release, elevated complement C3, and posttranslational modifications of fibrinogen and plasminogen are among the factors influencing altered clot structure and impaired fibrinolysis in T2DM.

CARDIOVASCULAR DIABETOLOGY (2021)

Article Biochemistry & Molecular Biology

Fibrin Network Formation and Lysis in Septic Shock Patients

Julie Brogaard Larsen et al.

Summary: This study found that septic shock patients exhibit distinct and abnormal clot-lysis profiles, which are associated with markers of coagulation and organ dysfunction.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Multidisciplinary Sciences

Elimination of fibrin γ-chain cross-linking by FXIIIa increases pulmonary embolism arising from murine inferior vena cava thrombi

Cedric Duval et al.

Summary: This study demonstrated that the lack of fibrin gamma-chain cross-linking leads to weakened thrombi that are more prone to fragmentation, increasing the risk of embolization. The findings also highlight the important role of fibrin gamma-chain cross-linking in clot stability and provide mechanistic targets for preventing thrombosis through selective modulation of activated Factor XIII-mediated fibrin alpha-chain cross-linking.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Hematology

Quantitative analysis of clot density, fibrin fiber radius, and protofibril packing in acute phase myocardial infarction

Aleksander Siniarski et al.

Summary: This study investigated clot formation and structure in patients with acute phase myocardial infarction (AMI). The results showed that clots in AMI patients were denser, less porous, and took longer to dissolve compared to healthy controls. The findings suggest that these dense clot structures may contribute to a prothrombotic environment in AMI.

THROMBOSIS RESEARCH (2021)

Review Medicine, General & Internal

Fibrin Clot Properties in Atherosclerotic Vascular Disease: From Pathophysiology to Clinical Outcomes

Michal Zabczyk et al.

Summary: Fibrin accumulation and characteristics play a role in the development of atherosclerosis and arterial thrombosis, with cardiovascular risk factors affecting fibrin clot properties. Effective therapies such as aspirin, statins, and anticoagulant agents can improve unfavorable alterations in fibrin clot characteristics.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Cardiac & Cardiovascular Systems

Coexistence and management of abdominal aortic aneurysm and coronary artery disease

Mateusz K. Holda et al.

CARDIOLOGY JOURNAL (2020)

Review Hematology

Effects of Post-Translational Modifications of Fibrinogen on Clot Formation, Clot Structure, and Fibrinolysis A Systematic Review

Judith J. de Vries et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)

Review Cardiac & Cardiovascular Systems

Bleeding in anticoagulated patients with atrial fibrillation: practical considerations

Anetta Undas et al.

KARDIOLOGIA POLSKA (2020)

Article Multidisciplinary Sciences

The distinctive structure and composition of arterial and venous thrombi and pulmonary emboli

Irina N. Chernysh et al.

SCIENTIFIC REPORTS (2020)

Article Medicine, General & Internal

Impaired Fibrinolysis in Patients with Isolated Aortic Stenosis is Associated with Enhanced Oxidative Stress

Jakub Siudut et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Review Cardiac & Cardiovascular Systems

New methodological approaches for assessing thrombus formation in cardiovascular disease

Kazuya Hosokawa et al.

KARDIOLOGIA POLSKA (2020)

Article Biochemical Research Methods

Plasma fibrin clot proteomics in patients with acute pulmonary embolism: Association with clot properties

Agata Hanna Bryk et al.

JOURNAL OF PROTEOMICS (2020)

Article Hematology

Effect of anticoagulants on fibrin clot structure: A comparison between vitamin K antagonists and factor Xa inhibitors

Julia S. Gauer et al.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2020)

Letter Cardiac & Cardiovascular Systems

Fibrin biofilm can be detected on intracoronary thrombi aspirated from patients with acute myocardial infarction

Michal Zabczyk et al.

CARDIOVASCULAR RESEARCH (2019)

Article Cardiac & Cardiovascular Systems

Restenosis is associated with prothrombotic plasma fibrin clot characteristics in endovascularly treated patients with critical limb ischemia

Tomasz Nowakowski et al.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2019)

Article Hematology

Sex difference in fibrin clot lysability: Association with coronary plaque composition

Ramshanker Ramanathan et al.

THROMBOSIS RESEARCH (2019)

Review Medical Laboratory Technology

Plasminogen activator inhibitor 1 in acute coronary syndromes

Marin Pavlov et al.

CLINICA CHIMICA ACTA (2019)

Article Multidisciplinary Sciences

Mendelian randomization evaluation of causal effects of fibrinogen on incident coronary heart disease

Cavin K. Ward-Caviness et al.

PLOS ONE (2019)

Review Cardiac & Cardiovascular Systems

Oxidized phospholipids as a unifying theory for lipoprotein(a) and cardiovascular disease

Michael B. Boffa et al.

NATURE REVIEWS CARDIOLOGY (2019)

Review Physiology

HOMOCYSTEINE MODIFICATION IN PROTEIN STRUCTURE/FUNCTION AND HUMAN DISEASE

Hieronim Jakubowski

PHYSIOLOGICAL REVIEWS (2019)

Review Hematology

Polyphosphate in thrombosis, hemostasis, and inflammation

Catherine J. Baker et al.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2019)

Article Medicine, Research & Experimental

A fibrin biofilm covers blood clots and protects from microbial invasion

Fraser L. Macrae et al.

JOURNAL OF CLINICAL INVESTIGATION (2018)

Article Hematology

Diagnosis and classification of congenital fibrinogen disorders: communication from the SSC of the ISTH

A. Casini et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)

Article Cardiac & Cardiovascular Systems

Erythrocyte compression index is impaired in patients with residual vein obstruction

Michal Zabczyk et al.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2018)

Article Cardiac & Cardiovascular Systems

Impaired fibrinolysis in degenerative mitral and aortic valve stenosis

Piotr Mazur et al.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2018)

Article Nanoscience & Nanotechnology

Sensing adhesion forces between erythrocytes and gamma ' fibrinogen, modulating fibrin clot architecture and function

Ana Filipa Guedes et al.

NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2018)

Article Hematology

Rivaroxaban and apixaban induce clotting factor Xa fibrinolytic activity

R. L. R. Carter et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)

Article Endocrinology & Metabolism

Prolonged Prothrombotic Effects of Antecedent Hypoglycemia in Individuals With Type 2 Diabetes

Elaine Chow et al.

DIABETES CARE (2018)

Article Hematology

Contraction of Blood Clots Is Impaired in Acute Ischemic Stroke

Valerie Tutwiler et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2017)

Article Cardiac & Cardiovascular Systems

Elevated NT-proBNP is associated with unfavorably altered plasma fibrin clot properties in atrial fibrillation

Pawel T. Matusik et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)

Article Hematology

Interplay between elevated cellular fibronectin and plasma fibrin clot properties in type 2 diabetes

Malgorzata Konieczynska et al.

THROMBOSIS AND HAEMOSTASIS (2017)

Review Medicine, General & Internal

Plasma fibrin clot structure and thromboembolism: clinical implications

Michal Zabczyk et al.

POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ (2017)

Article Cardiac & Cardiovascular Systems

Neutrophil Activation Promotes Fibrinogen Oxidation and Thrombus Formation in Behcet Disease

Matteo Becatti et al.

CIRCULATION (2016)

Article Biochemistry & Molecular Biology

Post-translational oxidative modification of fibrinogen is associated with coagulopathy after traumatic injury

Nathan J. White et al.

FREE RADICAL BIOLOGY AND MEDICINE (2016)

Article Hematology

How to Assess Fibrinogen Levels and Fibrin Clot Properties in Clinical Practice?

Anetta Undas

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2016)

Article Hematology

Novel mechanisms that regulate clot structure/function

Robert A.S. Ariëns

THROMBOSIS RESEARCH (2016)

Letter Cardiac & Cardiovascular Systems

Polyhedrocytes in intracoronary thrombi frompatients with ST-elevation myocardial infarction

Michal Zabczyk et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)

Article Hematology

TEG and ROTEM: Technology and clinical applications

David Whiting et al.

AMERICAN JOURNAL OF HEMATOLOGY (2014)

Article Cardiac & Cardiovascular Systems

Coronary thrombus composition: Links with inflammation, platelet and endothelial markers

Marcin Sadowski et al.

ATHEROSCLEROSIS (2014)

Review Hematology

The Northwick Park Heart Study: evidence from the laboratory

H. ten Cate et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)

Article Hematology

The effect of blood coagulation factor XIII on fibrin clot structure and fibrinolysis

E. L. Hethershaw et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)

Article Biochemistry & Molecular Biology

Mechanical Stability and Fibrinolytic Resistance of Clots Containing Fibrin, DNA, and Histones

Colin Longstaff et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2013)

Article Hematology

Impaired fibrinolysis is associated with the severity of aortic stenosis in humans

J. Natorska et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)

Article Cardiac & Cardiovascular Systems

Type 2 diabetes as a modifier of fibrin clot properties in patients with coronary artery disease

Maciej Bochenek et al.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2013)

Article Endocrinology & Metabolism

A novel mechanism for hypofibrinolysis in diabetes: the role of complement C3

K. Hess et al.

DIABETOLOGIA (2012)

Article Rheumatology

Scanning electron microscopy of fibrin networks in rheumatoid arthritis: a qualitative analysis

Etheresia Pretorius et al.

RHEUMATOLOGY INTERNATIONAL (2012)

Article Hematology

Stimulated in vivo synthesis of plasminogen activator inhibitor-1 in human adipose tissue

Mattias Ekstrom et al.

THROMBOSIS AND HAEMOSTASIS (2012)

Review Hematology

Factor XIII, clot structure, thrombosis

Zsuzsa Bagoly et al.

THROMBOSIS RESEARCH (2012)

Review Hematology

Fibrin Clot Structure and Function A Role in the Pathophysiology of Arterial and Venous Thromboembolic Diseases

Anetta Undas et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)

Article Hematology

Clot Architecture Is Altered in Abdominal Aortic Aneurysms and Correlates With Aneurysm Size

D. Julian A. Scott et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)

Article Hematology

Assessment of Genetic Determinants of the Association of γ′ Fibrinogen in Relation to Cardiovascular Disease

Rehana S. Lovely et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)

Review Medicine, General & Internal

MECHANISMS OF DISEASE The Hemostatic System as a Modulator of Atherosclerosis

Julian Ilcheff Borissoff et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Hematology

Effects of Cigarette Smoke Exposure on Clot Dynamics and Fibrin Structure An Ex Vivo Investigation

Rajat S. Barua et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)

Article Hematology

The effect of ethanol and its metabolism on fibrinolysis

Marlien Pieters et al.

THROMBOSIS AND HAEMOSTASIS (2010)

Article Hematology

Unfavorably altered fibrin clot properties in patients with active rheumatoid arthritis

Beata Kwasny-Krochin et al.

THROMBOSIS RESEARCH (2010)

Article Hematology

Fibrin clot properties in acute ischemic stroke: relation to neurological deficit

Anetta Undas et al.

THROMBOSIS RESEARCH (2010)

Article Hematology

Effects of Aspirin on Clot Structure and Fibrinolysis Using a Novel In Vitro Cellular System

R. A. Ajjan et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)

Article Hematology

Hypofibrinolysis is a risk factor for arterial thrombosis at young age

Ana H. C. Guimaraes et al.

BRITISH JOURNAL OF HAEMATOLOGY (2009)

Letter Hematology

Effect of cigarette smoking on plasma fibrin clot permeability and susceptibility to lysis

Anetta Undas et al.

THROMBOSIS AND HAEMOSTASIS (2009)

Article Clinical Neurology

Fibrinogen γ′ in ischemic stroke -: A case-control study

Elim Y. L. Cheung et al.

STROKE (2008)

Article Hematology

Heritability of clot formation, morphology, and lysis - The EuroCLOT study

Angela M. Carter et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)

Article Hematology

Fibrinogen and fibrin: scaffold proteins in hemostasis

Susan T. Lord

CURRENT OPINION IN HEMATOLOGY (2007)

Article Hematology

The effect of glycaemic control on fibrin network structure of type 2 diabetic subjects

Marlien Pieters et al.

THROMBOSIS AND HAEMOSTASIS (2006)

Article Hematology

Altered fibrin architecture is associated with hypofibrinolysis and premature coronary atherothrombosis

J. P. Collet et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)

Article Multidisciplinary Sciences

Fibrin fibers have extraordinary extensibility and elasticity

W. Liu et al.

SCIENCE (2006)

Article Hematology

Plasma homocysteine affects fibrin clot permeability and resistance to lysis in human subjects

Anetta Undas et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)

Letter Hematology

Lipoprotein(a) as a modifier of fibrin clot permeability and susceptibility to lysis

A Undas et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)

Article Endocrinology & Metabolism

The influence of type 2 diabetes on fibrin structure and function

EJ Dunn et al.

DIABETOLOGIA (2005)

Article Hematology

Marked increase of fibrin gel permeability with very low dose ASA treatment

A Antovic et al.

THROMBOSIS RESEARCH (2005)

Article Hematology

Genetics of fibrin clot structure:: a twin study

EJ Dunn et al.

BLOOD (2004)

Article Hematology

What is all that thrombin for?

KG Mann et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)